Utah Moves to Ban Conversion Therapy

Utah Moves to Ban Conversion Therapy

Utah’s Property just unanimously handed a conversion treatment ban, in a exceptional gain for LGBTQ+ Utah inhabitants.  Property Monthly bill 228 would enshrine into legislation presently-present protections that were established beneath an government buy in 2020. Whilst it bans a wide variety of pursuits when it will come to defining what exactly conversion therapy entails, it also […]

LGBTQ+ Patients Have Higher Risk of Breast Cancer Recurrence

LGBTQ+ Patients Have Higher Risk of Breast Cancer Recurrence

LGBTQ+ clients with breast cancer encounter delays in analysis and have worse results than cisgender heterosexual individuals, according to investigate released in JAMA Oncology. Scientists located that LGBTQ+ sufferers have a better threat of cancer recurrence, and they are additional very likely to decrease their oncologist’s advisable study course of remedy. This retrospective, situation-regulate study […]

Here’s Why Big Pharma Spends More On Ads Pushing Lower Benefit Drugs, Study Suggests

Here’s Why Big Pharma Spends More On Ads Pushing Lower Benefit Drugs, Study Suggests

Topline Major pharma spends much more revenue on promotion for medicine that have lessen health and fitness gains for people, according to a analyze published in JAMA on Tuesday, shedding new light on the pretty much uniquely American observe amid fierce discussion in excess of irrespective of whether direct-to-customer prescription drug ads need to be […]

Columbia Care Celebrates Launch of Adult Use Cannabis Sales in Missouri | News

Columbia Care Celebrates Launch of Adult Use Cannabis Sales in Missouri | News

NEW YORK–(Enterprise WIRE)–Feb 6, 2023– Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), just one of the premier and most experienced cultivators, manufacturers and stores of hashish goods in the U.S., introduced it commenced adult-use profits on February 4 at its Cannabist i dispensary, situated in Hermann, […]

From Clinical Trials to Real-World Practice, Experts Examine the Best Options for TNBC

From Clinical Trials to Real-World Practice, Experts Examine the Best Options for TNBC

CancerNetwork® recently hosted a first-of-its-kind Tweet Chat with co-hosts Hope S. Rugo, MD, and Paolo Tarantino, MD. Together, they reviewed a patient case of a 52-year-old woman who had been diagnosed with stage IIA triple-negative breast cancer (TNBC) and went into detail regarding treatment options for the metastatic population. Rugo, a professor of medicine, and […]